Camber Pharmaceuticals Inc. recalls
Every recall we track for Camber Pharmaceuticals Inc. — 5 in all, from 2019–2023 — plus the complaints and injury reports the public filed about them.
Recalls per year, by danger level
Recalls from Camber Pharmaceuticals Inc. peaked in 2019 (3); 5 since 2017.
All FDA recall records for Camber Pharmaceuticals Inc. since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 2 | 1 | 3 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 1 | 1 |
| 2023 | 0 | 0 | 1 | 0 | 1 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 0 | 0 | 0 | 0 |
What to do if you have a recalled Camber Pharmaceuticals Inc. product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Camber Pharmaceuticals Inc. recalls
3 shown- Lower riskDrug
Camber Pharmaceuticals Inc. recalls Atovaquone Oral Suspension USP, 750 mg/5 mL, Packaged in 210 mL bottle, Manufactured for: Camber Pharmaceuticals, Inc.,
Camber Pharmaceuticals recalls Atovaquone Oral Suspension USP (750 mg/5 mL) due to Bacillus cereus contamination in repackaged product. This poses a risk of infection from improper use.
Camber PharmaceuticalsMar 13, 2023 - UnratedDrug
Camber Pharmaceuticals, Inc recalls Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber
Camber Pharmaceuticals recalls Lacosamide Oral Solution due to p-Hydroxybenzoic Acid content failing excipient specifications. This affects prescription 200mL bottles manufactured in 2024. No remedy specified in official notice.
CamberDec 6, 2022 - Lower riskDrug
Camber Pharmaceuticals Inc recalls Losartan Potassium Tablets USP, 50 mg, Rx only, a) 30 count (NDC 31722-701-30), b) 90 count (NDC 31722-701-90), c) 1000
Camber Pharmaceuticals recalls 50mg Losartan Potassium Tablets due to trace amounts of NMBA detected in the active ingredient. This may pose a contamination risk during medication use.
Camber PharmaceuticalsFeb 28, 2019
Camber Pharmaceuticals Inc. recall questions
How many recalls has Camber Pharmaceuticals Inc. had?
5 recalls from Camber Pharmaceuticals Inc. are on record with U.S. safety agencies, from 2019–2023.
What is the most recent Camber Pharmaceuticals Inc. recall?
Camber Pharmaceuticals Inc. recalls Atovaquone Oral Suspension USP, 750 mg/5 mL, Packaged in 210 mL bottle, Manufactured for: Camber Pharmaceuticals, Inc.,, dated Mar 13, 2023. Every Camber Pharmaceuticals Inc. recall is listed on this page, newest first.
What should I do if I have a recalled Camber Pharmaceuticals Inc. product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Camber Pharmaceuticals Inc. recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.